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Testing of tissues from vacuum aspiration and from chorionic 
villi sampling revealed that placenta and chorion contained 
Zika virus RNA. Isolation of Zika virus from the karyotype 
cell culture confirmed active viral replication in embryonic 
cells. All the tests performed suggest that the spontaneous 
abortion in this woman was likely associated with a symp-
tomatic Zika virus infection occurring early in pregnancy. 
These findings provide further evidence of the association 
between Zika virus infection early in pregnancy and trans-
placental infection, as well as embryonic damage, leading 
to poor pregnancy outcomes (2). Given that embryo loss 
had probably occurred days before maternal-related symp-
toms, we hypothesize that spontaneous abortion happened 
early during maternal viremia. The prolonged viremia in the 
mother beyond the first week after symptom onset concurs 
with other recent reports (1,5). However, persistent viremia 
3 weeks after pregnancy outcome has not been described 
previously and underscores the current lack of knowledge 
regarding the persistence of Zika virus infection. Because 
we identified Zika virus RNA in placental tissues, our find-
ings reinforce the evidence for early gestational placental 
tissue as the preferred target for viral tropism (2,4). Finally, 
although laboratory tests were performed to dismiss other 
maternal infections (see online Technical Appendix), the at-
tribution of Zika virus as the cause of the spontaneous abor-
tion must be interpreted with caution, because a non–Zika-
related etiology cannot be entirely ruled out. Further studies 
are warranted to investigate the natural history of Zika virus 
infection in pregnant women.
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We report identification of an Oropouche virus strain in a fe-
brile patient from Ecuador by using metagenomic sequenc-
ing and real-time reverse transcription PCR. Virus was iso-
lated from patient serum by using Vero cells. Phylogenetic 
analysis of the whole-genome sequence showed the virus 
to be similar to a strain from Peru.
Oropouche virus (OROV) is a negative-sense, single-stranded RNA virus (family Bunyaviridae, genus Or-
thobunyaviridae) with a tripartite genome consisting of large 
(L), medium (M), and small (S) segments. OROV causes 
a self-limiting acute febrile illness, Oropouche fever (1). 
Since its discovery in Trinidad in 1955 (2), >30 outbreaks of 
OROV have been reported from Brazil, Panama, and Peru, 
demonstrating the ability of this midgeborne virus to cause 
epidemics. Approximately 500,000 cases of Oropouche 
fever have been reported, making OROV one of the most 
clinically significant orthobunyaviruses (1). Two previous 
studies reported unconfirmed infections in Ecuador by using 
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serologic or antigenic evidence (3,4). We describe whole-ge-
nome sequencing and virus isolation of OROV in Ecuador.
We collected a blood sample from a consenting 
41-year-old male patient in Esmeraldas, Ecuador, who 
sought treatment in April 2016 after 7 days of fever, head-
ache, joint pain, muscle pain, and nausea. The patient re-
ported that he had been in Esmeraldas for >3 months and 
had not traveled outside the province during that time. 
RNA was extracted from plasma of the blood sample and 
tested at Universidad San Francisco de Quito, Ecuador, and 
Public Health England, UK, for dengue virus (DENV), chi-
kungunya virus (CHIKV), Zika virus, yellow fever virus, 
Mayaro virus, Plasmodium spp., Leptospira spp., and Rick-
ettsia spp. by using real-time reverse transcription PCR 
(rRT-PCR) and conventional RT-PCR assays developed 
in-house or acquired commercially (Genesig, Primerdesign 
Ltd., Cambridge, UK). The sample gave borderline results 
for DENV (quantitation cycle [Cq] 35.3) and CHIKV (Cq 
36.6; reference ranges ≤35 positive, 35–40 borderline, >40 
negative) and negative results for the other pathogens. 
As an initial screen for other pathogens, we applied unbi-
ased metagenomic sequencing. Analysis of sequencing reads 
by using Kraken, a system for assigning taxonomic labels to 
individual reads (5), identified 1% reads (5,016 of 464,444) 
as specific to OROV. We generated an OROV consensus 
sequence by mapping reads to a reference sequence, which 
resulted in coverage of 69% for S, 76% for M, and 79% for 
L OROV viral RNA segments (online Technical Appendix, 
http://wwwnc.cdc.gov/EID/article/24/2/17-1569-Techapp1.
pdf). We classified 1,228 reads as DENV serotype 1, all of 
which mapped to a single 732-nt region of the DENV-1 ref-
erence genome. No reads mapped to CHIKV.
After confirmation of the presence of OROV by using 
a validated rRT-PCR (6), we attempted to isolate OROV by 
using Vero and C6/36 cell lines inoculated with the patient’s 
plasma. We confirmed virus replication by detecting increas-
ing OROV RNA over time by using rRT-PCR. We obtained 
whole-genome sequences by sequencing viral RNA from 
harvested OROV supernatant; each genome segment was 
sequenced at average depths of coverage of 55,532× for S, 
4,954× for M, and 5,674× for L segments. We deposited se-
quences in GenBank (online Technical Appendix). Genetic 
organization was similar to that of other OROV strains: seg-
ment lengths 952 nt for S, 4,387 nt for M, and 6,852 nt for L. 
Phylogenetic analysis (online Technical Appendix) 
showed that the virus we isolated, OROV/EC/Esmeral-
das/087/2016, was most closely related to a strain isolated 
from a patient in Peru during 2008 and excluded the pos-
sibility of the virus being a reassortant orthobunyavirus, 
such as Iquitos virus. This finding suggests a potential in-
troduction across the Peru–Ecuador border; however, fur-
ther investigation is required to understand the origin and 
incidence of OROV in Ecuador. The known urban OROV 
vector, the Culicoides paraensis midge, is absent in the Pa-
cific Coast region, including Esmeraldas (S. Zapata, pers. 
comm., 2017 Aug 31), which raises the question of alter-
native insect vectors in OROV transmission. Culex mos-
quitoes have previously been implicated as vectors in the 
OROV urban cycle, notably C. quinquefasciatus (1), a spe-
cies that is widespread throughout South America (7).
DENV and CHIKV rRT-PCR results for this patient 
were inconclusive. The small proportion of DENV reads in 
the metagenomic data suggests DENV-1 infection is pos-
sible. Using ELISA to detect DENV and CHIKV-specific 
antibodies may help clarify the results.
It is likely that cases of Oropouche fever go unreported 
or misdiagnosed. Clinical features of the disease are similar 
to those of other viral, protozoan, and bacterial diseases pre-
viously reported in Ecuador (1,4,8,9). OROV might spread 
unnoticed across a wide geographic area, as suggested by 
this unexpected detection. Several studies have success-
fully documented the use of metagenomic sequencing for 
virus identification in febrile patients (10); this approach 
is becoming more practicable as costs decrease, the major 
benefit being the ability to detect unexpected or novel viral 
sequences, as evidenced by this detection of OROV. 
This work highlights the need for increased surveil-
lance of OROV in Ecuador and effective differential diag-
nostic assays to distinguish between emerging pathogens 
sharing common clinical descriptions to those already cir-
culating. To clarify the true prevalence of this disease in 
Ecuador, the OROV rRT-PCR assay will be used to screen 
archived and newly collected samples from a cohort of pa-
tients seeking treatment for acute undifferentiated febrile 
illness during 2016–2017.
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In September 1955, a virus was isolated from a 24-year-old forest worker from the community of Vega de Oropouche, near the town of Sangre Grande, on the island of Trinidad (country: Trinidad and Tobago), who presented with fever, backache, and 
cough, which resolved spontaneously after 3 days. The virus was isolated from the patient’s blood by intracranial inoculation 
of suckling mice at the Trinidad Regional Virus Laboratory. Five years later, the virus was isolated from Coquillettidia venezu-
elensis (Theobald) mosquitoes collected ≈30 miles away in the Bush Bush Forest. The urban vector was later identified as the 
midge Culicoides paraensis, but the sylvatic vector remains unknown. Virus has been isolated from the three-toed sloth, which 
is believed to be involved in the sylvatic transmission cycle.
The virus was shown to be unique but antigenically related to Simbu virus, which had recently been described from South 
Africa. It therefore became a member of the large family of bunyaviruses.1
The virus, Oropouche virus, named in keeping with the tradition of designating arboviruses by using local geographic names, 
stems from the name of the village, a nearby swamp (wetland), and river. It derives from an Amerindian word, but the ancient 
meaning of the word is not clear.
Oropouche virus has since proven to be one of the most common arthropodborne viruses infecting humans in the tropics of the 
Western Hemisphere. Clinical signs of infection include headache, myalgia, arthralgia, and chills; no deaths have been reported. It 
has been estimated to have infected more than half a million persons in Brazil alone, and there have also been large outbreaks in 
Panama and Peru. In keeping with the recent emergence of other arboviruses such as West Nile, chikungunya, and Zika viruses, 
Oropouche virus is a candidate for possible further urban spread and therefore warrants increased surveillance and diagnostics.
Oropouche [oʹro-pooʺche] Virus
etymologia
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1In 2017, the International Committee on Taxonomy of Viruses (ICTV) reclassified the family Bunyaviridae, elevating the family to an 
order. The formal taxonomic placement of Oropouche virus is order Bunyavirales; family Peribunyaviridae; genus Orthobunyavirus; 
species; Oropouche orthobunyavirus.
